Immutep (IMMP) Enterprise Value (2011 - 2025)
Immutep (IMMP) posted Enterprise Value of -$65.1 million for Q4 2025, up 21.64% on a QoQ basis from -$83.1 million in Q2 2025, and up 37.51% year-over-year from -$47.3 million in Q4 2024.
Immutep (IMMP) Enterprise Value (2011 - 2025) Analysis & Trends
Immutep's Enterprise Value history runs 15 years deep, the most recent figure standing at -$65.1 million for Q4 2025.
- Quarterly Enterprise Value rose 37.51% year-over-year to -$65.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$65.1 million (up 37.51% YoY) and the FY2025 annual result came in at -$83.1 million, up 22.1% from the prior year.
- Enterprise Value was -$65.1 million for Q4 2025 at Immutep, up from -$83.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$44.9 million in Q4 2022 and bottomed at -$106.6 million in Q2 2024.
- A 5-year average of -$73.0 million and a median of -$70.1 million in 2021 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2021 — Enterprise Value plunged 170.46% — and 2022, when it soared 38.12%.
- Immutep's Enterprise Value stood at -$72.6 million in 2021, then jumped by 38.12% to -$44.9 million in 2022, then plunged by 50.32% to -$67.5 million in 2023, then tumbled by 54.23% to -$104.1 million in 2024, then surged by 37.51% to -$65.1 million in 2025.
- Business Quant data shows IMMP's Enterprise Value at -$65.1 million in Q4 2025, -$83.1 million in Q2 2025, and -$104.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -1.91 Bn |
| 10 | Immutep | 569.08 Mn | 569.08 Mn | - | -65.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -65.09 Mn |
| Jun 30, 2025 | -83.06 Mn |
| Dec 31, 2024 | -104.15 Mn |
| Jun 30, 2024 | -106.62 Mn |
| Dec 31, 2023 | -67.53 Mn |
| Jun 30, 2023 | -82.49 Mn |
| Dec 31, 2022 | -44.92 Mn |
| Jun 30, 2022 | -57.30 Mn |
| Dec 31, 2021 | -72.60 Mn |
| Jun 30, 2021 | -46.66 Mn |
| Dec 31, 2020 | -40.11 Mn |
| Jun 30, 2020 | -17.25 Mn |
| Dec 31, 2019 | -14.02 Mn |
| Jun 30, 2019 | -11.61 Mn |
| Dec 31, 2018 | -18.65 Mn |
| Jun 30, 2018 | -17.77 Mn |
| Jun 30, 2017 | -9.19 Mn |
| Mar 31, 2017 | -10.51 Mn |
| Jun 30, 2016 | -15.59 Mn |
| Jun 30, 2015 | -5.26 Mn |